# A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS

> **NCT01864005** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 60 (actual)

## Conditions studied

- Non-ST or ST Elevation Acute Coronary Syndromes

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01864005
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01864005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01864005, "A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01864005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*